SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Oct-24 5:48 PM View: | Camp4 Therapeutics Corp (CAMP) | 15-Oct-24 | Conversion Duplicate | 2,018,820 | -- | -- | 100% 0 to 2.02M | |
15-Oct-24 5:48 PM View: | Camp4 Therapeutics Corp (CAMP) | 15-Oct-24 | Market Purchase Duplicate | 909,090 | $11.00 | $9,999,990.00 | 45% 2.02M to 2.93M | |
13-Sep-24 6:56 PM View: | Skye Bioscience, Inc. (SKYE) | 13-Sep-24 | Sale Duplicate | 13,837 | $6.06 | $83,852.20 | (< 1%) 9.93M to 9.91M | |
13-Sep-24 6:56 PM View: | Skye Bioscience, Inc. (SKYE) | 11-Sep-24 | Private Sale Duplicate | 252,500 | $6.60 | $1,666,500.00 | (2%) 10.18M to 9.93M | |
15-Mar-24 10:00 PM View: | Skye Bioscience, Inc. (SKYE) | 13-Mar-24 | Grant | 450,000 | $10.00 | $4,500,000.00 | 5% 9.73M to 10.18M | |
02-Feb-24 4:35 PM View: | Skye Bioscience, Inc. (SKYE) | 31-Jan-24 | Grant | 5,206,070 | $2.31 | $12,026,000.00 | 115% 4.52M to 9.73M | |
22-Aug-23 5:21 PM View: | Skye Bioscience, Inc. (SKYE) | 18-Aug-23 | Grant | 1,130,860,032 | $0.01 | $8,782,770.00 | 883482000% 0 to 1.13B | |
27-Feb-23 9:55 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Grant | 5,798,480 | -- | -- | 100% 0 to 5.8M | |
07-Dec-21 5:25 PM View: | Pear Therapeutics, Inc. (PEAR) | 03-Dec-21 | Grant | 18,631,800 | $0.11 | $2,000,000.00 | 100% 0 to 18.63M | |
12-Nov-20 5:50 PM View: | 5:01 Acquisition Corp. (FVAM) | 12-Nov-20 | Acquisition (other) Duplicate | 5,126 | $10.00 | $51,260.00 | 1% 360.0K to 365.13K | |
20-Oct-20 8:36 PM View: | 5:01 Acquisition Corp. (FVAM) | 16-Oct-20 | Acquisition (other) Duplicate | 360,000 | $10.00 | $3,600,000.00 | 100% 0 to 360.0K | |
28-May-20 9:12 PM View: | Scpharmaceuticals Inc. (SCPH) | 26-May-20 | Market Purchase | 578,034 | $8.65 | $4,999,990.00 | 18% 3.25M to 3.83M | (36%) |
20-Feb-14 2:53 PM View: | Flexion Therapeutics, Inc. (FLXN) | 18-Feb-14 | Conversion Duplicate | 1,499,780 | -- | -- | 12194% 12.3K to 1.51M |